摘要
目的探究将宫腔填塞联合水囊压迫止血治疗方案应用于凶险性前置胎盘患者妇产科治疗中的效果,评价其应用意义。方法通过于该院中患者数据库中抽取时间段内2016年4月—2018年5月间收入的所有接受宫腔填塞联合水囊压迫止血治疗的凶险性前置胎盘患者作为研究对象,录入其中符合要求患者76例开展实验,应用两组均分法,将所有患者分为对照组(n=38)与实验组(n=38)。对照组患者采用八字缝合以及子宫动脉上行支结扎手术方案进行治疗,实验组患者则选择宫腔填塞联合水囊压迫止血方案进行治疗,治疗完成后对所有患者术后24 h、48 h的出血量进行记录,并将水囊及纱布取出后,记录患者的阴道流血量。统计患者治疗后再出血发生率、子宫切除率和弥散性血管内凝血发生率。结果在实验结果中显示,实验组患者的在再出血发生率13.16%(5/38)(χ~2=7.962,P=0.005)、弥散性血管内凝血发生率7.89%(3/38)(χ~2=5.604,P=0.018)、子宫切除率0.00%(0/38)(χ~2=4.222,P=0.040)明显低于对照组的42.11%(16/38)、28.95%(11/38)、10.53%(4/38),组间差异有统计学意义(P<0.05)。同时实验结果显示,在治疗后,实验组患者的24 h(87.5±2.9)mL(t=33.470,P=000)、48 h(41.9±3.4)mL(t=48.956,P=000)、取出水囊和纱布后的阴道流血量(19.4±6.5)mL(t=9.317,P=000)低于对照组(112.6±3.6)mL、(84.2±4.1)mL、(34.4±7.5)mL,各数据对比差异有统计学意义(P<0.05)。结论在对凶险性前置胎盘患者进行非药物治疗时,应用宫腔填塞联合水囊压迫止血治疗方案,能够有助于提高患者的治疗效果,降低患者在各个时间点的阴道出血量,有助于改善患者的子宫、阴道功能,是一种积极且有效的治疗方案,值得推广使用。
Objective To investigate the effect of intrauterine tamponade combined with water sac compression hemostasis in the treat-ment of gynecological obstetrics in patients with sinister placenta previa,and evaluate its application significance.Methods All the sinister placenta previa patients who received uterine tamponade combined with water-sac compression hemostasis during the period from April 2016 to May 2018 in the patient database of the hospital were selected as subjects.76 patients who met the requirements were enrolled in the study.All patients were divided into control group(n=38)and experimental group(n=38).The patients in the control group were treated with eight-segment suture and uterine artery ascending branch ligation.The patients in the experimental group were treated with intrauterine tamponade combined with water-sac compression hemostasis.The bleeding volume of all patients after 24 h and 48 h after treatment was completed.After recording and taking out the water bladder and gauze,the patient’s vaginal bleeding was recorded.The incidence of rebleeding,the rate of hysterectomy,and the incidence of disseminated intravascular coagulation after treatment were counted.Results In the experimental results,the incidence of rebleeding in the experimental group was13.16%(5/38))(χ~2=7.962,P=0.005),and the rate of disseminated intravascular coagulation was 7.89%(3/38)(χ~2=5.604,P=0.018),hysterectomy rate of 0.00%(0/38)(χ~2=4.222,P=0.040)was significantly lower than that of the control group of 42.11%(16/38),28.95%(11/38)),and 10.53%(4/38),and the difference between the groups was statistically significant(P<0.05).At the same time,the experimental results showed that after treatment,the patients in the experimental group received 24 h(87.5±2.9)mL(t=33.470,P=0.000),48 h(41.9±3.4)mL(t=48.956,P=000),and vaginal bleeding after taking out the water bladder and gauze of(19.4±6.5)mL(t=9.317,P=000)was lower than that of the control group(112.6±3.6)mL,(84.2±4.1)mL,and(34.4±7.5)mL.The difference of the data was statistically significant(P<0.05).Conclusion In the case of non-drug treatment for patients with dangerous placenta previa,the application of intrauterine tamponade combined with water sac compression hemostasis can help improve the patient’s therapeutic effect,reduce the amount of vaginal bleeding at various time points,and help improve the patient’s uterus and vaginal function.It is a positive and effective method.The treatment plan is worth promoting.
作者
江俊
JIANG Jun(Department of Obstetrics and Gynecology,Xishuangbanna People's Hospital,Xishuangbanna,Yunnan Province,666100 China)
出处
《世界复合医学》
2020年第1期93-95,105,共4页
World Journal of Complex Medicine
关键词
凶险性前置胎盘
修复
水囊压迫止血
宫腔填塞
治疗方案
Sinister placenta previa
Repair
Water sac compression hemostasis
Uterine cavity filling
Treatment plan
